Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: Potential loss of T cell epitopes

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 2, 2008, Pages 110-116

  Tang, Y L ^a   Lu, J H ^a   Cao, L ^a   Wu, M H ^a   Peng, S P ^a   Zhou, H D ^a   Huang, C ^a   Yang, Y X ^a   Zhou, Y H ^a   Chen, Q ^a   Li, X L ^a   Zhou, M ^a   Li, G Y ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epitope; Genetic variation; Immune recognition; Latent membrane protein 1; Tumorigenicity

Indexed keywords

DNA; EPITOPE; HLA A2 ANTIGEN; LATENT MEMBRANE PROTEIN 1;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; CARCINOGENICITY; CD4+ T LYMPHOCYTE; CELL LOSS; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE DELETION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; NONHUMAN; SEQUENCE ANALYSIS; TUMOR BIOPSY; VIRUS CARCINOGENESIS; VIRUS STRAIN;

HUMAN HERPESVIRUS 4;

EID: 41149146446     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000200006     Document Type: Article

References (26)

1. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10: 803-821.
2. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883-889.
3. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002; 12: 431-441.
4. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5: 423-428.
5. Hu LF, Zabarovsky ER, Chen F, Cao SL, Emberg I, Klein G, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Wrol 1991; 72 (Part 10): 2399-2409.
6. Lin JC, Cherng JM, Lin HJ, Tsang CW, Liu YX, Lee SP. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA-A2-restricted 'epitope-loss variant'. J Gen Virol 2004; 85: 2023-2034.
7. Nagamine M, Takahara M, Kishibe K, Nagato T, Ishii H, Bandoh N, et al. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes 2007; 34: 47-54.
8. Saechan V, Mori A, Mitarnun W, Settheetham-Ishida W, Ishida T. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. J Clin Wrol 2006; 36: 119-125.
9. Khanna R, Burrows SR, Nicholls J, Poulsen LM. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA-A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur J Immunol 1998; 28: 451-458.
10. Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N. Potential selec6n of LMP1 variants in nasopharyngeal carcinoma. J Virol 2004; 78: 868-881.
11. Cheung ST, Leung SF, Lo KW, Ghiu KW, Tam JS, Fok TF, et al. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer 1998; 76: 399-406.
12. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64: 1972-1974.
13. Lin JC, Lin SC, De BK, Chan WP, Evatt BL, Chan WC. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993; 81: 3372-3381.
14. Leen A, Meij P, Redchenko I, Middeldorp J, Bloemena E, Rickinson A, et al. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J Virol 2001; 75: 8649-8659.
15. Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 2002; 44: 203-215.
16. Hu LF, Chen F, Zheng X, Emberg I, Cao SL, Christensson B, et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 1993; 8: 1575-1583.
17. Liu H, Andreansky S, Diaz G, Hogg T, Doherty PC. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice. J Immunol 2002; 168: 3477-3483.
18. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12: 48-54.
19. Bickham K, Munz C, Tsang ML, Larsson M, Fonteneau JF, Bhardwaj N, et al. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. J Clin Invest 2001: 107: 121-130.
20. Cheung ST, Lo KW, Leung SF, Chan WY, Choi PH, Johnson PJ, et al. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 1996; 66: 711-712.
21. Leung SY, Yuen ST, Chung LP, Chan AS, Wong MP. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int J Cancer 1997; 72: 225-230.
22. Pai S, O'Sullivan B, Abdul-Jabbar I, Peng J, Connolly G, Khanna R, et al. Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunol Cell Biol 2007; 85: 370-377.
23. Stevenson PG. Immune evasion by gamma-herpesviruses. Curr Opin Immunol 2004; 16: 456-462.
24. Duraiswamy J, Burrows JM, Bharadwaj M, Burrows SR, Cooper L, Pimtanothai N, et al. Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. J Virol 2003; 77: 7401-7410.
25. Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC. Functional assays of HLA-A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. J Biomed Sci 2005; 12: 925-936.
26. Tang YL, Lu JH, Wu MH, Huang C, Cao L, Peng SP, et al. Lytic replication and induction to production visualization recombinant Epstein Barr virus. Progr Biochem Biophys 2007; 34: 418-424.